ChemScene

ChemScene logo

Imagine the power of people with a common purpose to build relationships that create value for you and your business. This is ChemScene. Every day, our people work with you to ensure you have what you need to achieve your commercial and scientific pursuits. We make sure everything we do honors that relationship starting from our commitment to ensuring that our chemicals are held to the most rigorous quality standards in the world, to the way we engage with our customers and communities to do business responsibly.

Company Website

Product Listing

R110| ChemScene 5mg  | >98%

ChemScene

R110 is a potent, competitive inhibitor of macrophage migration inhibitory factor 2 (MIF2) tautomerase with an IC50 of 15 μM. R110 has the potential for the research of cancer diseases.IC50 & Target:IC50: 15 μM (MIF2)

More Information Supplier Page

R243| ChemScene 1mg  | >98%

ChemScene

R243 is a potent and selective CCR8 antagonist. R243 inhibits CCL1/CCR8 interaction and inhibits CCR8 signaling and chemotaxis. R243 has antinociceptive and anti-inflammatory effects[2].In Vitro: R243 has CCR8-antagonistic effects on CCL1-induced Ca2+ flux and CCL1-driven peritoneal macrophages aggregation. R243 attenuates secretion of TNF-α, IL-6, and most strikingly IL-10 from wild-type peritoneal macrophages (WT PMφ). R243-treated […]

More Information Supplier Page

RA375| ChemScene 100mg  | >98%

ChemScene

RA375 is a RPN13 (26S proteasome regulatory subunit) inhibitor. RA375 activates UPR signaling, ROS production and apoptosis. RA375 exhibits ten-fold greater activity against cancer lines than RA190, reflecting its nitro ring substituents and the addition of a chloroacetamide warhead.In Vivo: RA375 (10 mg/kg, ip) inhibits proteasome function and reduces ovarian tumor burden in mice.

More Information Supplier Page

RA839| ChemScene 50mg  | >98%

ChemScene

RA839 is a noncovalent small molecule binder to Keap1 with a Kd of ~6 μM and selective activator of Nrf2 signaling. RA839 prevents the induction of both inducible nitric-oxide synthase expression and nitric oxide release in response to lipopolysaccharides in macrophages. RA839 is a selective inhibitor of the Keap1/Nrf2 interaction and a useful tool compound […]

More Information Supplier Page

Rabdosiin| ChemScene 10mg  | >98%

ChemScene

Rabdosiin is a tetramer of caffeic acid isolated from the stem of Ocimum sanctum. Rabdosiin possess anti-allergic activity, anti-HIV activity and inhibition on DNA topoisomerase.

More Information Supplier Page

RAD16-I (hydrochloride)| ChemScene 5mg  | >98%

ChemScene

RAD16-I hydrochloride, a soft nanofibrous self-assembling peptide, is a suitable microenvironment for human mesenchymal stem cells’ (hMSC) proliferation and differentiation into chondrocytes. RAD16-I is a well-studied ionic complementary peptide was used as a model to check potential amyloid-like staining properties of SAPNFs[2].

More Information Supplier Page

Raffinose| ChemScene 100mg  | >98%

ChemScene

Raffinose (Melitose), a non-digestible short-chain?oligosaccharide, is a trisaccharide composed of galactose, glucose, and fructose and can be found in many plants. Raffinose (Melitose) can be hydrolyzed to D-galactose and sucrose by the enzyme α-galactosidase (α-GAL).IC50 & Target: IC50: short-chain?oligosaccharide

More Information Supplier Page

Ralaniten triacetate| ChemScene 50mg  | >98%

ChemScene

Ralaniten triacetate (EPI-506), the pro-drug of Ralaniten, is a first-in-class, orally active androgen receptor (AR) N-terminal domain (NTD) inhibitor. Ralaniten triacetate shows activity against both full length and resistance-related AR species, including AR-v7[2].In Vitro: Ralaniten triacetate (EPI-506) targets the N-terminal domain of the androgen receptor (AR), and is used for metastatic castration-resistant prostate cancer (mCRPC) […]

More Information Supplier Page

Raleukin| ChemScene 50mg  | >98%

ChemScene

Raleukin (AMG-719) is a recombinant, nonglycosylated human interleukin-1 receptor (IL-1R) antagonist. Raleukin (AMG-719) is the first biological agent to block the pro-inflammatory effects[2].IC50 & Target: IL-1R.In Vivo: Combined Etanercept (5 mg/kg, ip) and Anakinra (100 mg/kg, ip. daily for 7 days) substantially improves marginal mass human islet engraftment in immunodeficient mice[2].Raleukin (AMG-719) enhances tumor growth […]

More Information Supplier Page

Ralfinamide| ChemScene 50mg  | >98%

ChemScene

Ralfinamide (FCE-26742A) is an orally available Na+ blocker derived from α-aminoamide, with function of suppressing pain[2].IC50 & Target: Na+channelIn Vivo: Ralfinamide (30 mg/kg, 60 mg/kg; p.o.; twice daily; 42 days) treated with Ralfinamide (80 mg/kg; p.o.; twice daily; 7 days) preoperatively suppresses neuropathic pain.

More Information Supplier Page

Ramoplanin| ChemScene 50mg  | >98%

ChemScene

Ramoplanin is a broad-spectrum lipoglycodepsipeptide antibiotic derived from the Actinoplanes spp with with activity against gram-positive bacteria[2].IC50 & Target:BacteriaIn Vitro: Ramoplanin exerts its bactericidal activity against gram-positive aerobic and anaerobic bacteria by blocking peptidoglycan synthesis via lipid II.In Vivo: Ramoplanin (100, 500 μg/ml; p.o.; for 8 days) suppresses vancomycin-resistant Enterococcus (VRE) to undetectable level during […]

More Information Supplier Page

Randialic acid B| ChemScene 5mg  | >98%

ChemScene

Randialic acid B, a triterpenoid compound, is a formyl peptide receptor 1 (FPR1) antagonist. Randialic acid B blocks FPR1 in human neutrophils and attenuates psoriasis-like inflammation in vivo.In Vitro: Randialic acid B (0.1-3 μM; for 5 min) selectively inhibits reactive oxygen species production, elastase release, and CD11b expression in human neutrophils activated by FPR1. Randialic […]

More Information Supplier Page

Ranibizumab| ChemScene 1mg  | >98%

ChemScene

Ranibizumab (RG-6321) is a humanized anti-VEGF monoclonal antibody fragment and can recognize all VEGF-A isoforms?(VEGF110, VEGF121, and VEGF165). Ranibizumab slows vision loss in vivo and is used for wet age-related macular degeneration (AMD) research.In Vitro: Ranibizumab (RG-6321) is a humanized anti-VEGF monoclonal antibody fragment (IgG antigen-binding fragment (Fab-Y0317)[2]. Ranibizumab (0.0625-0.25 mg/ml; 72 hours) results in […]

More Information Supplier Page

Rapanone| ChemScene 5mg  | >98%

ChemScene

Rapanone is a natural benzoquinone. Rapanone exhibits a broad spectrum of biological actions, including anti-tumor, antioxidant, anti-inflammatory, antibacterial and antiparasitic. Rapanone also is a potent and selective human synovial PLA2 inhibitor, with an IC50 of 2.6 μM[2].In Vitro: Rapanone (10-40 μM; 24 h) inhibits the cell viability, with IC50s of 35.58 μM and 27.89 μM […]

More Information Supplier Page

Raptinal| ChemScene 10mg  | >98%

ChemScene

Raptinal, a agent that directly activates caspase-3, initiates intrinsic pathway caspase-dependent apoptosis. Raptinal is able to rapidly induce cancer cell death by directly activating the effector caspase-3, bypassing the activation of initiator caspase-8 and caspase-9[2].In Vitro: H. pylori?infection-induced apoptosis resistance in gastric epithelial cells triggered by Raptinal.?Treatment with 10?μM of Raptinal for 2?h induces the […]

More Information Supplier Page

Rasarfin| ChemScene 1mg  | >98%

ChemScene

Rasarfin is a dual Ras and ARF6 inhibitor.In Vitro: Rasarfin also potently inhibits agonist-induced ERK1/2 signaling by GPCRs, and MAPK and Akt signaling by EGFR, as well as prevents cancer cell proliferation.Rasarfin blocks GPCR internalization through inhibition of ARF6.Rasarfin treatment results in a dose-dependent reduction in MDA-MB-231 cells. Rasarfin inhibits the recruitment of the clathrin […]

More Information Supplier Page

Rasburicase| ChemScene 1mg  | >98%

ChemScene

Rasburicase is a recombinant urate oxidase and a hyperuricemia inhibitor. Rasburicase converts uric acid into allantoin, making it easier to be cleared by the kidneys and improving the elevated level of uric acid in the blood.

More Information Supplier Page

Razoxane| ChemScene 250mg  | >98%

ChemScene

Razoxane (ICRF 159) is an antiangiogenic topoisomerase II inhibitor, can be used for the research of renal cell carcinoma (RCC).In Vitro: Razoxane (30 mg/kg; i.p.) exhibits antimetastatic effects in a rat osteosarcoma model.In Vivo: Early treatment with Razoxane (30 mg/kg i.p. from day -2 to +14) shows a greater inhibition of pulmonary metastases than later […]

More Information Supplier Page